SA
Therapeutic Areas
Astrocyte Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AST-004 | Concussion (mild Traumatic Brain Injury) | Phase 2 |
| Unnamed programs | Traumatic Brain Injury (TBI) | Preclinical |
Leadership Team at Astrocyte Pharmaceuticals
WS
William S. Korinek
Co-Founder and Chief Executive Officer
JD
James D. Lechleiter
Co-Founder and Advisor
TE
Theodore E. Liston
Vice-President of Research
KS
Kevin Sheth
Advisor
LM
Lisa Manna
Vice-President of Clinical Development Operations
RB
Russell B. Poe
Head of Chemistry and Manufacturing Controls (CMC)
JL
Jeffrey L. Ives
Director
JM
Jeffrey M. Arnold
Director
JS
Jackson Streeter
Director
CG
Christine Gallagher
Director